Our news

  • Researchers at the Nordic Cochrane Centre have examined randomized trials of the effect of cognitive behavioural therapy (CBT) on preventing new suicide attempts in people admitted after a suicide attempt. They found that the therapy halves the risk of suicide.The systematic review assessed 10 randomised trials, which included eight trials from...
    4 December 2017
  • Recently, France has conducted an independent review of their breast screening programme and the Steering Committee concluded that the programme should either be terminated or strongly reformed. A trio of leading experts within mammography screening, Vice Director Karsten Juhl Jørgensen from our centre, Professor Alexandra Barratt from the...
    13 November 2017
  • On the 26th May 2016, Professor Peter C. Gøtzsche and Deputy Director Karsten Juhl Jørgensen, along with others, filed an official complaint about how the European Medicines Agency handled the HPV safety issue. Below is an overview of the most important correspondence about this complaint:2 NovemberOur Assessment of the European...
    2 November 2017
  • Researchers from the Nordic Cochrane Centre have reviewed animal studies for effects of long-term use of drugs against Attention Deficit Hyperactivity Disorder (ADHD). The findings show that long-term use may impair the reproductive system, with some studies showing delayed sexual maturation. There were a total of 17 studies available, published...
    11 October 2017
  • This autumn a new documentary, “Diagnosing Psychiatry,” will shed light on the scientific career and efforts of Professor Peter C. Gøtzsche in changing the field of psychiatry. It portrays the uphill battle Peter experiences when he, supported by the patients, advocates for a more humane psychiatric practice, with very little use of psychiatric...
    5 October 2017
  • Nordic Cochrane Centre at the Global Evidence Summit 2017This year, two of our PhD students participating at the Global Evidence (GE) Summit in Cape Town, South Africa presented research from our Centre. The GE Summit is the first conference ever with a focus solely on evidence-based policy. The summit is aimed at everyone interested in evidence-...
    13 September 2017
  • A Cochrane systematic review on immediate-release methylphenidate for adults with attention deficit hyperactivity disorder (ADHD) was withdrawn from the Cochrane Library on 26 May 2016 after substantial criticism of its methods and flawed conclusions. Retraction of scientific papers on this basis is unusual but can be necessary. The withdrawn...
    27 July 2017
  • Today, evidence-based medicine is facing multiple serious challenges. Some claim that EBM has been hijacked by vested interests. We see an emphasis on surrogate outcomes with uncertain clinical value, on statistically significant results with marginal clinical benefit, and even outright manipulation of data. Publication bias and selective outcome...
    22 June 2017
  • Cochrane, a global independent network of researchers, professionals, patients, carers and people interested in health, is proud to announce its newest Associate Centre, Cochrane Sweden.The new Cochrane Sweden Centre is located in the city of Lund, and is affiliated with the Department of Research & Development / Section for HTA Analysis,...
    10 May 2017
  • With most votes of the 11 candidates, Professor Peter C. Gøtzsche joined the Cochrane Governing Board early in 2017. The Board is currently comprised of 13 members. Some are elected by the Cochrane Collaboration’s members and some are external directors appointed by the Board.Peter is one of the co-founders of Cochrane and has made a number of...
    10 May 2017

Pages

Subscribe to Our news